Impinj, Inc. (NASDAQ: PI) — 2020 Form 10-K
Reporting period: Fiscal year ended December 31, 2020. The filing is an annual report, not a standalone quarterly filing; selected fourth-quarter results are included below. Financial amounts are in U.S. dollars.
Business context
Impinj develops and sells RAIN RFID products that connect physical items to digital applications. Its products include endpoint integrated circuits (ICs), reader ICs, readers and gateways. It relies on third-party manufacturing and channel partners, and serves retail, supply chain and logistics, and other markets. Endpoint ICs remain its principal revenue source.
Financial performance and liquidity
| Metric | FY 2020 | FY 2019 |
|---|---|---|
| Revenue | $138.9 million | $152.8 million |
| Gross profit / margin | $65.1 million / 46.9% | $74.0 million / 48.4% |
| Operating loss | $47.1 million | $21.7 million |
| Net loss | $51.9 million | $23.0 million |
| Net loss per share | $2.28 | $1.05 |
| Adjusted EBITDA (non-GAAP) | $(11.5) million | $1.6 million |
| Operating cash flow | $(16.9) million | $4.7 million |
| Cash, cash equivalents and short-term investments (year-end) | $106.1 million | $116.5 million |
| Working capital (year-end) | $143.8 million | $157.3 million |
Capital expenditures were $3.1 million. Investing cash outflow was $36.3 million, driven mainly by purchases of short-term investments, partly offset by maturities. Financing cash inflow was $9.9 million, primarily from employee stock-option exercises and the employee stock purchase plan.
At year-end, the company reported $86.3 million principal amount of 2.00% convertible senior notes due 2026, with a $54.6 million balance-sheet carrying value. Management said available cash and short-term investments should cover anticipated cash needs for at least 12 months under its current operating plan. Net operating lease commitments were $19.7 million.
Fourth-quarter results and changes versus comparable periods
- Q4 2020 revenue was $36.4 million, down from $40.8 million in Q4 2019, but up from $28.2 million in Q3 2020.
- Q4 2020 gross margin was 47.8%, compared with 48.8% in Q4 2019. Net loss was $15.7 million, versus $7.7 million a year earlier.
- For FY 2020, revenue fell 9% year over year. Endpoint IC revenue rose $4.7 million to $102.3 million, while systems revenue declined $18.6 million to $36.6 million.
- Management attributed the annual revenue and gross-profit declines mainly to lower systems sales, including the absence of a comparable large logistics gateway deployment from 2019 and COVID-related delays. Lower systems mix contributed to the 1.5 percentage-point reduction in gross margin.
- Operating expenses increased $16.5 million, led by higher R&D and G&A costs. The latter included $5.4 million of company-paid securities litigation settlement and related costs. Stock-based compensation rose to $25.7 million from $18.5 million.
Outlook, risks and unusual items
- Outlook: No numerical revenue or earnings guidance is provided. Management expects uncertainty in RAIN adoption and customer deployments to continue, and said COVID-19 effects and the timing of any 2021 recovery were unclear. It expects R&D spending to increase in absolute dollars, while monitoring conditions and potentially adjusting investment.
- Products: The M700 endpoint IC and R700 reader reached full production by year-end, but demand ramped more slowly than anticipated. M700 endpoint IC demand recovery remained uncertain.
- Market and customer concentration: Avery Dennison accounted for 32% of FY 2020 revenue and Arizon for 10%. Retail is the largest end market. COVID-19, customer concentration, channel inventory and project-based systems sales increase volatility.
- Supply and pricing: Endpoint IC wafers are sourced from sole suppliers without long-term supply contracts; management highlighted potential semiconductor capacity constraints. Annual endpoint IC price negotiations, competition and product mix can pressure revenue and margins. Inventory excess and obsolescence reduced FY 2020 gross margin by 2.2 percentage points.
- Legal matters: A securities class-action settlement closed in November 2020; the company paid $5.4 million of the $20.0 million settlement, with insurers contributing $14.6 million. NXP patent litigation remains ongoing in the U.S. and China. A related derivative-action settlement, including up to $0.9 million of attorneys’ fees funded by insurers and governance changes, had not received preliminary court approval as of the filing.
- Subsequent event: In February 2021, Impinj announced a go-to-market restructuring expected to eliminate about nine positions and incur $1.0–$1.5 million in employee-related charges plus $0.1 million in legal costs.
- Other considerations: The company has a history of losses, with an accumulated deficit of $314.7 million. Management reported effective disclosure controls and internal control over financial reporting; the auditor did not attest to internal controls because Impinj qualified as an emerging growth company.
Important facts for investors to verify
- Whether endpoint IC demand and systems deployments recover, and whether M700 and R700 adoption accelerates.
- Whether revenue concentration, customer/channel inventory, and reliance on key wafer suppliers create material sales or fulfillment risk.
- Whether cash and investments remain adequate given operating cash burn, planned investment and the 2026 convertible notes.
- Whether gross margins improve as product mix, pricing, and inventory charges change.
- Developments in NXP patent cases and approval or completion of the derivative-action settlement.
- Actual costs and operational effects of the 2021 restructuring, and any further changes in COVID-19 impacts.